Breaking News Instant updates and real-time market news.

ADVM

Adverum Biotechnologies

$11.48

-0.075 (-0.65%)

04:55
08/13/19
08/13
04:55
08/13/19
04:55

Adverum Biotechnologies management to meet with Piper Jaffray

Meetings to be held in New York, NY on August 12 in Baltimore, MD on August 13 hosted by Piper Jaffray.

  • 13

    Aug

  • 11

    Sep

ADVM Adverum Biotechnologies
$11.48

-0.075 (-0.65%)

04/15/19
PIPR
04/15/19
NO CHANGE
Target $8
PIPR
Overweight
Adverum clinical hold likely short-lived, says Piper Jaffray
Piper Jaffray analyst Tyler Van Buren believes the clinical hold placed on Adverum Biotechnologies' investigational new drug application will be short-lived.The clinical hold is unrelated to safety and Adverum responded to the FDA within days, Van Buren tells investors in a research note. This gives him confidence that patients could be dosed in the second cohort later this quarter. Further, the disclosure that initial efficacy data from the first six patients will be reported later this year is earlier than anticipated and suggests that the company may be seeing encouraging signs of activity at the first dose level, says the analyst. He keeps an Overweight rating on Adverum Biotechnologies with an $8 price target.
05/17/19
PIPR
05/17/19
NO CHANGE
Target $12
PIPR
Overweight
Adverum Biotechnologies price target raised to $12 from $8 at Piper Jaffray
Piper Jaffray analyst Tyler Van Buren raised his price target for Adverum Biotechnologies to $12 from $8 citing the positive ADVM-022 efficacy update. The analyst applauds management saying the ADVM-022 clinical hold was effectively lifted in just over a month. Further, management provided "some very bullish comments" by describing the ongoing results as "exciting" and demonstrating a "robust preliminary anatomical response" and "the potential to provide sustained efficacy following a single intravitreal injection," Van Buren tells investors in a research note. As such, he believes "impressive" reductions in central retinal thickness must have already been observed. The analyst maintains an Overweight rating on Adverum shares.
06/13/19
RAJA
06/13/19
INITIATION
RAJA
Market Perform
Adverum Biotechnologies resumed with a Market Perform at Raymond James
Raymond James analyst Dane Leone resumed Adverum Biotechnologies with a Market Perform rating.
07/29/19
RHCO
07/29/19
NO CHANGE
Target $12
RHCO
Hold
Adverum Biotechnologies price target raised to $12 from $4 at SunTrust
SunTrust analyst Joon Lee raised his price target on Adverum Biotechnologies to $12 after holding a call with its management about its ongoing trial of ADVM-02 in wet age-related macular degeneration, or wAMD. The analyst says he is including the program in his valuation given its recent progress, even though the longer-term safety issues remain an "overhang". Lee keeps his Hold rating on the stock given the "very high" hurdle for safety in wAMD gene therapy.

TODAY'S FREE FLY STORIES

10:20
08/21/19
08/21
10:20
08/21/19
10:20
General news
The U.S. July existing home sales report beat estimates »

The U.S. July existing…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
08/21/19
08/21
10:17
08/21/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOOM

DMC Global

$42.78

1.375 (3.32%)

10:17
08/21/19
08/21
10:17
08/21/19
10:17
Conference/Events
DMC Global management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 13

    Nov

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
08/21/19
08/21
10:16
08/21/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFL

Aflac

$49.57

-2.29 (-4.42%)

10:15
08/21/19
08/21
10:15
08/21/19
10:15
Options
AFLAC put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
08/21/19
08/21
10:15
08/21/19
10:15
General news
Breaking General news story  »

Week of 8/16 EIA…

HSGX

Histogenics

$0.22

0.0005 (0.23%)

10:14
08/21/19
08/21
10:14
08/21/19
10:14
Hot Stocks
Histogenics merger partner Ocugen granted FDA orphan designation »

Ocugen's treatment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYCN

Cyclerion Therapeutics

$9.59

0.8 (9.10%)

10:12
08/21/19
08/21
10:12
08/21/19
10:12
Upgrade
Cyclerion Therapeutics rating change  »

Cyclerion Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFL

Aflac

$49.65

-2.21 (-4.26%)

10:11
08/21/19
08/21
10:11
08/21/19
10:11
Recommendations
Aflac analyst commentary  »

Aflac third sector sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLFD

Clearfield

$10.98

(0.00%)

, WSG

Wanda Sports

$4.12

0.22 (5.64%)

10:10
08/21/19
08/21
10:10
08/21/19
10:10
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

CLFD

Clearfield

$10.98

(0.00%)

WSG

Wanda Sports

$4.12

0.22 (5.64%)

INMB

INmune Bio

$6.30

0.46 (7.88%)

CLGX

CoreLogic

$47.28

0.49 (1.05%)

HUBB

Hubbell

$127.70

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 05

    Sep

  • 12

    Sep

  • 13

    Nov

CREE

Cree

$52.88

-5.31 (-9.13%)

, HA

Hawaiian Holdings

$23.94

-1.5 (-5.90%)

10:10
08/21/19
08/21
10:10
08/21/19
10:10
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

CREE

Cree

$52.88

-5.31 (-9.13%)

HA

Hawaiian Holdings

$23.94

-1.5 (-5.90%)

CIM

Chimera

$19.52

-0.17 (-0.86%)

SYBX

Synlogic

$3.25

-0.22 (-6.34%)

JAZZ

Jazz Pharmaceuticals

$134.12

-2.42 (-1.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 04

    Sep

  • 05

    Sep

  • 09

    Sep

  • 30

    Oct

NOW

ServiceNow

$263.94

8.44 (3.30%)

, EEX

Emerald Expositions Events

$9.73

0.24 (2.53%)

10:10
08/21/19
08/21
10:10
08/21/19
10:10
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

NOW

ServiceNow

$263.94

8.44 (3.30%)

EEX

Emerald Expositions Events

$9.73

0.24 (2.53%)

PSA

Public Storage

$261.11

0.66 (0.25%)

LSI

Life Storage

$104.00

0.68 (0.66%)

ONDK

On Deck Capital

$3.26

0.025 (0.77%)

RDFN

Redfin

$18.28

0.83 (4.76%)

RMAX

RE/MAX Holdings

$27.38

0.71 (2.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 28

    Aug

  • 18

    Sep

  • 27

    Oct

  • 13

    Nov

  • 12

    Dec

  • 16

    Dec

10:10
08/21/19
08/21
10:10
08/21/19
10:10
General news
FX Action: The dollar »

FX Action: The dollar…

10:10
08/21/19
08/21
10:10
08/21/19
10:10
General news
U.S. July existing home sales rebounded 2.5% to 5.420 M »

U.S. July existing home…

PFE

Pfizer

$34.96

0.34 (0.98%)

10:03
08/21/19
08/21
10:03
08/21/19
10:03
Hot Stocks
Pfizer announces additional half billion dollar investment for Sanford facility »

Pfizer announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 16

    Sep

LKSD

LSC Communications

$1.34

0.01 (0.75%)

10:03
08/21/19
08/21
10:03
08/21/19
10:03
Hot Stocks
UBM acquires commingle operations from LSC Communications for $11.25M in cash »

LSC Communications and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:02
08/21/19
08/21
10:02
08/21/19
10:02
General news
Existing Home Sales data reported »

July Existing Home Sales…

HURN

Huron

$60.80

(0.00%)

10:02
08/21/19
08/21
10:02
08/21/19
10:02
Conference/Events
Huron management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 29

    Aug

  • 10

    Sep

  • 11

    Sep

  • 17

    Sep

  • 18

    Sep

HURN

Huron

$60.80

(0.00%)

10:01
08/21/19
08/21
10:01
08/21/19
10:01
Conference/Events
Huron management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 29

    Aug

  • 10

    Sep

  • 11

    Sep

  • 17

    Sep

  • 18

    Sep

SPY

SPDR S&P 500 ETF Trust

$292.80

2.77 (0.96%)

, SPX

S&P 500

$0.00

(0.00%)

10:01
08/21/19
08/21
10:01
08/21/19
10:01
General news
Trump tweets about German bonds, asks 'Where is the Federal Reserve?' »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$292.80

2.77 (0.96%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$107.98

9.94 (10.14%)

10:00
08/21/19
08/21
10:00
08/21/19
10:00
Hot Stocks
Lowe's says seeing increased Pro customer service scores »

Says: Has laundry list of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 25

    Sep

TSLA

Tesla

$222.22

-3.48 (-1.54%)

10:00
08/21/19
08/21
10:00
08/21/19
10:00
Options
Tesla bear spends $318K on Oct downside »

Tesla bear spends $318K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 23

    Sep

09:57
08/21/19
08/21
09:57
08/21/19
09:57
Conference/Events
The Food & Drug Law Institute to hold a webinar »

Anthony Anscombe, Partner…

GLD

SPDR Gold Shares

$141.65

-0.56 (-0.39%)

09:56
08/21/19
08/21
09:56
08/21/19
09:56
Options
Upside call Seller in SPDR Gold Trust »

Upside call Seller in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$99.51

13.935 (16.28%)

, LOW

Lowe's

$109.03

10.985 (11.20%)

09:55
08/21/19
08/21
09:55
08/21/19
09:55
Options
Early notable gainers among liquid option names on August 21st »

Notable gainers among…

TGT

Target

$99.51

13.935 (16.28%)

LOW

Lowe's

$109.03

10.985 (11.20%)

BBBY

Bed Bath & Beyond

$8.06

0.32 (4.13%)

URBN

Urban Outfitters

$21.97

1.04 (4.97%)

PCG

PG&E

$11.67

0.04 (0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

  • 11

    Nov

  • 19

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.